These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19953918

  • 1. [Prognosis of thymectomy in treatment of ocular myasthenia gravis and relevant influencing factors].
    Deng Y, Zhang X.
    Zhonghua Yi Xue Za Zhi; 2009 Jul 21; 89(27):1922-5. PubMed ID: 19953918
    [Abstract] [Full Text] [Related]

  • 2. Extended transsternal thymectomy for the treatment of ocular myasthenia gravis.
    Liu Z, Feng H, Yeung SC, Zheng Z, Liu W, Ma J, Zhong FT, Luo H, Cheng C.
    Ann Thorac Surg; 2011 Dec 21; 92(6):1993-9. PubMed ID: 22115207
    [Abstract] [Full Text] [Related]

  • 3. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM, Gamez J, Vilallonga R, Ruiz C, Azem J, López-Cano M, Armengol M.
    Eur J Cardiothorac Surg; 2008 Nov 21; 34(5):1062-7. PubMed ID: 18760934
    [Abstract] [Full Text] [Related]

  • 4. Thymectomy in the treatment of ocular myasthenia gravis.
    Roberts PF, Venuta F, Rendina E, De Giacomo T, Coloni GF, Follette DM, Richman DP, Benfield JR.
    J Thorac Cardiovasc Surg; 2001 Sep 21; 122(3):562-8. PubMed ID: 11547310
    [Abstract] [Full Text] [Related]

  • 5. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA, Scala S, Jones HR.
    Muscle Nerve; 2010 Mar 21; 41(3):379-84. PubMed ID: 19918767
    [Abstract] [Full Text] [Related]

  • 6. [Prognostic factors related to recurrence after extended thymectomy in patients with myasthenia gravis].
    Men LN, Liu WB, Chen ZG, He XT, Zhang Y, Huang R.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 03; 88(21):1446-9. PubMed ID: 18953847
    [Abstract] [Full Text] [Related]

  • 7. Prognosis of the short-term efficacy of thymectomy for myasthenia gravis with serum protein profiles.
    Wu GY, Pang JZ, Cheng C, Lu JJ, Ma J, Gu Y, Zhong FT, Luo HH.
    Chin Med J (Engl); 2009 Jul 20; 122(14):1625-30. PubMed ID: 19719962
    [Abstract] [Full Text] [Related]

  • 8. Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.
    Huang CS, Hsu HS, Huang BS, Lee HC, Kao KP, Hsu WH, Huang MH.
    Acta Neurol Scand; 2005 Aug 20; 112(2):108-14. PubMed ID: 16008537
    [Abstract] [Full Text] [Related]

  • 9. [Long-term efficacy of enlarged thymectomy in treatment of myasthenia gravis and relevant influencing factors: study of 410 cases].
    Liu WB, Men LN, Chen ZG, Luo HH, Huang RX.
    Zhonghua Yi Xue Za Zhi; 2006 Dec 05; 86(45):3182-5. PubMed ID: 17313782
    [Abstract] [Full Text] [Related]

  • 10. Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients.
    Hong YH, Kwon SB, Kim BJ, Kim BJ, Kim SH, Kim JK, Park KS, Park KJ, Sung JJ, Sohn EH, Lee YB, Jeong D, Joo IS, Choi BO, Choi YC, Korean Research Group for Neuromuscular Diseases.
    J Neurol Sci; 2008 Oct 15; 273(1-2):10-4. PubMed ID: 18602121
    [Abstract] [Full Text] [Related]

  • 11. [Response to thymectomy and analysis of influencing factors in the treatment of children with myasthenia gravis].
    Li Y, Liu WB, Luo CM, Feng HY, Huang X, Wang HY, Qiu L, Huang RX.
    Zhonghua Yi Xue Za Zhi; 2012 May 08; 92(17):1170-3. PubMed ID: 22883003
    [Abstract] [Full Text] [Related]

  • 12. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis.
    Zhang J, Zhang Z, Zhang H, Cui Y, Chen Y, Lv P, Zhang P.
    Orphanet J Rare Dis; 2022 Aug 09; 17(1):309. PubMed ID: 35945595
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes following extended thymectomy for myasthenia gravis: report of 17 cases.
    Hase R, Sugiura H, Fukunaga A, Takahashi H, Simozawa E, Kondo S.
    Ann Thorac Cardiovasc Surg; 2006 Jun 09; 12(3):203-6. PubMed ID: 16823336
    [Abstract] [Full Text] [Related]

  • 14. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM, Gamez J, Azem J, Fort JM, López-Cano M, Vilallonga R, Buera M, Armengol M.
    Curr Med Res Opin; 2007 Jun 09; 23(6):1269-78. PubMed ID: 17559724
    [Abstract] [Full Text] [Related]

  • 15. Different characteristics of nonthymomatous generalized myasthenia gravis with and without oropharyngeal involvement.
    Yu L, Li J, Ma S, Jiang J, Wang T, Gamliel Z, Jing Y, Zhang X, Krasna MJ.
    Ann Thorac Surg; 2007 Nov 09; 84(5):1694-8. PubMed ID: 17954087
    [Abstract] [Full Text] [Related]

  • 16. [The significance of Titin antibody in diagnosing myasthenia gravis with thymoma].
    Chen X, Lü C, Qiao J.
    Zhonghua Yi Xue Za Zhi; 2001 Sep 25; 81(18):1118-20. PubMed ID: 11766610
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic factors of myasthenic crisis after extended thymectomy in patients with generalized myasthenia gravis].
    Liu WB, Men LN, Tang BY, Huang RX.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 24; 86(39):2737-40. PubMed ID: 17199991
    [Abstract] [Full Text] [Related]

  • 18. [Clinical characteristics and outcome of myasthenia gravis with and without thymoma after operation].
    Wang RW, Jiang YG, Xue ZQ, Zhao YP, Ma Z.
    Zhonghua Wai Ke Za Zhi; 2004 May 07; 42(9):536-9. PubMed ID: 15196366
    [Abstract] [Full Text] [Related]

  • 19. [310 cases of thymectomy for myasthenia gravis].
    Wang YZ, Zhen WJ, Yan WZ, Tong HF, Sun YG, Guo H.
    Zhonghua Wai Ke Za Zhi; 2003 Aug 07; 41(8):607-9. PubMed ID: 14505537
    [Abstract] [Full Text] [Related]

  • 20. Effects of thymectomy on late-onset myasthenia gravis without thymoma.
    Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Arimura K, Osame M, Hattori T.
    Clin Neurol Neurosurg; 2007 Dec 07; 109(10):858-61. PubMed ID: 17904281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.